In MIAPaCa-2 cells, BAPTA-AM partially attenuated AdipoRon-associated loss of MTT signal. Its own reduction of the vehicle-group signal and nonmonotonic response limit a simple rescue interpretation. [3]
Suppression of astrocytic calcium-wave propagation
Cell-based study · Rat forebrain mixed cultures, 14–21 days in vitro; neuron-free or sparse fields [1]
BAPTA-AM loading suppressed propagation while a local calcium response remained.
Literature-Reported Treatment Conditions
- Treatment concentration
- 10 or 30 μM
- Exposure duration
- 1.5 h loading at 37°C; imaging after rinse
- Method
- Fluo-3 imaging after mechanical stimulation
- Vehicle
- DMSO ≤0.25%; 0.01% pluronic during loading
- Co-treatment
- 5 μM fluo-3 AM; indicator-only controls; lower-affinity analog comparisons
- Reported limits
- Intracellular BAPTA concentration was not quantified.
Methods and source locations
Compound reported in the paper: BAPTA-AM; Compound label in the paper: BAPTA-AM
Reported AM-ester reagent; supplier attribution does not validate the current catalog lot.
Results: An exogenous Ca2+ chelator blocks astrocytic Ca2+ waves; Figure 1; Methods: loading/imaging
Failure to propagate a calcium wave: Fluo-3 fluorescence — Results: An exogenous Ca2+ chelator blocks astrocytic Ca2+ waves; Figure 1A
Partial modification of AdipoRon-associated MTT loss
Cell-based study · Human MIAPaCa-2 pancreatic cancer cells [3]
Partial attenuation of AdipoRon-associated MTT loss coexisted with lower signal in BAPTA-AM-only controls.
Literature-Reported Treatment Conditions
- Treatment concentration
- 0, 1, 2 or 5 μM
- Exposure duration
- 1 h pretreatment, then 40 h with AdipoRon or vehicle
- Method
- MTT assay
- Vehicle
- AdipoRon solvent: DMSO; BAPTA-AM solvent not specified
- Co-treatment
- 100 μM AdipoRon or vehicle
- Reported limits
- Independent biological replicate number not specified for Figure 3B; Methods describes triplicate wells.
Methods and source locations
Compound reported in the paper: BAPTA-AM; Compound label in the paper: BAPTA-AM
Reported AM-ester reagent; supplier attribution does not validate the current catalog lot.
Figure 3B and caption; Reagents; Cell growth and viability assay; Statistics
MTT-based survival in AdipoRon and vehicle groups: MTT absorbance at 550 nm — Figure 3B; Cell growth and viability assay
Acute inhibition of native cardiac IKr
Cell-based study · Isolated canine ventricular myocytes; conventional whole-cell voltage clamp at 37°C [2]
Acute IKr suppression persisted with intracellular BAPTA buffering.
Literature-Reported Treatment Conditions
- Treatment concentration
- 5 μM external BAPTA-AM
- Exposure duration
- 5 min exposure; 5 min washout
- Method
- Conventional voltage clamp
- Vehicle
- DMSO stock diluted into bath; final vehicle control not separately specified
- Co-treatment
- 10 mM BAPTA in pipette; 1 μM nisoldipine and 1 μM HMR 1556 in bath
- Reported limits
- No concentration-response IC50 determined in this adopted design.
Methods and source locations
Compound reported in the paper: BAPTA-AM; Compound label in the paper: BAPTA-AM
Reported AM-ester reagent; supplier attribution does not validate the current catalog lot.
Figure 6; Results: Effect of BAPTA-AM on IKr current; Methods: Conventional voltage clamp
IKr tail-current density: Tail current on repolarization to −40 mV — Results: Effect of BAPTA-AM on IKr current, first paragraph; Figure 6